Viewpoint: FTC will be healthcare’s biggest headache until 2025

With the Senate’s confirmation of Alvaro Bedoya to the Federal Trade Commission on May 11, Democrats now have a 3-2 majority in the FTC, which will likely lead to heightened scrutiny of competition in healthcare, Paul Keckley, PhD, wrote May 16 in The Keckley Report.

Advertisement

With each commissioner serving a seven-year term, Democrats will be the majority in the FTC until at least January 2025. If Democrats lose control of the House and the Senate in November, one of the few cards they have to play is through the FTC, he said.

With the Democratic majority, healthcare organizations should prepare themselves for more transparency and regulatory scrutiny, Dr. Keckley said.

“That means independent board members will be liable for oversights and willful noncompliance and management teams will be held to a higher level of accountability,” Dr. Keckley said. “That means increased fines for non-compliance and calls for major reforms. That means the FTC will be a headache to healthcare organizations unable to demonstrate effectively the alignment of their growth strategies with enhanced competition and protections for consumers.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.